Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 11 days ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 25 days ago Next-gen menopause treatments have blockbuster potential. Can women, doctors and payers be convinced? - 7 months ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts Biologic License Application for Biosimilar Denosumab - 16 days ago Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 18 days ago FDA Approves Palopegteriparatide for Treatment of Hypoparathyroidism - 3 months ago Teva Launches Generic Formulation of Liraglutide in US - 5 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 7 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 11 months ago FDA Approves Vosoritide for Children With Achondroplasia - about 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs - 21 days ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 4 months ago Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush - 6 months ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - 29 days ago STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago
5	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 2 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago
7	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Which GLP-1 Drug Was Tied to a Signal of Suicidal Thoughts? - 3 months ago
8	Kristen Monaco MedPage Today	Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 4 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 5 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 8 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 8 months ago More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk - 9 months ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - 10 months ago U.S. Rep's Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammograms - 11 months ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - 11 months ago Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passage - 11 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 11 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 12 months ago Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes - about 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - about 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - about 1 year ago
9	Michael Calore Wired Editor at @WIRED, cohost @gadgetlab podcast. 94110 editingpodcasting	Semaglutide for the People - 4 months ago
10	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Are T-DXd Results in HER2-Low/Ultralow Breast Cancer Practice-Changing? - 5 months ago T-DXd Could Be 'Practice-Changing' in HER2-Expressing Gynecologic Cancers - 11 months ago Uterine Cancer Trials Made Waves This Year, Experts Say - 12 months ago GLP-1 Receptor Agonists Help With Weight Loss for HIV Patients - about 1 year ago

Journalists covering GHQ